Strange attractors: DAMPs and autophagy link tumor cell death and immunity

Cell Death and Disease

Volumn 4, Issue 12, 2013, Pages

  Hou, W ^a   Zhang, Q ^a   Yan, Z ^a,b   Chen, R ^a,c   Zeh III, H J ^a   Kang, R ^a   Lotze, M T ^a   Tang, D ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

apoptosis; autophagy; cancer; DAMPs; immunity; necrosis

Indexed keywords

ADENOSINE TRIPHOSPHATE;

APOPTOSIS; AUTOPHAGY; CANCER CELL; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL ORGANELLE; CELL STRESS; CELL SURVIVAL; CELLULAR PARAMETERS; DAMAGE ASSOCIATED MOLECULAR PATTERN; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; INFLAMMATION; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY;

ANIMALS; AUTOPHAGY; CELL DEATH; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS;

EID: 84891754287     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.493     Document Type: Review

References (71)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011; 144: 646-674
2. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12: 401-410
3. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009; 9: 353-363
4. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV et al. Molecular definitions of cell death subroutines: Recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012; 19: 107-120
5. Chen L, Park SM, Tumanov AV, Hau A, Sawada K, Feig C et al. CD95 promotes tumour growth. Nature 2010; 465: 492-496
6. Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, Pinon J et al. Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 2010; 24: 1602-1607
7. Michalak EM, Vandenberg CJ, Delbridge AR, Wu L, Scott CL, Adams JM et al. Apoptosispromoted tumorigenesis: Gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 2010; 24: 1608-1613
8. Tang D, Lotze MT, Kang R, Zeh HJ. Apoptosis promotes early tumorigenesis. Oncogene 2011; 30: 1851-1854
9. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: An ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11: 700-714
10. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721
11. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571-580
12. Rock KL, Kono H. The inflammatory response to cell death. Annu Rev Pathol 2008; 3: 99-126
13. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S et al. Differential antigen processing by dendritic cell subsets in vivo. Science 2007; 315: 107-111
14. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32
15. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010; 140: 798-804
16. Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: Signal 0s that spur autophagy and immunity. Immunol Rev 2012; 249: 158-175
17. Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell death in cancer therapy. Annu Rev Immunol 2012; 31: 51-72
18. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12: 860-875
19. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54-61
20. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-1059
21. Spisek R, Charalambous A, Mazumder A, Vesole DH, Jagannath S, Dhodapkar MV. Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: Therapeutic implications. Blood 2007; 109: 4839-4845
22. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-Associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 2012; 61: 215-221
23. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009; 15: 1170-1178
24. Ramakrishnan R, Huang C, Cho HI, Lloyd M, Johnson J, Ren X et al. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy. Cancer Res 2012; 72: 5483-5493
25. Ciampricotti M, Hau CS, Doornebal CW, Jonkers J, de Visser KE. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat Med 2012; 18: 344-346; author reply 346
26. Krause KH, Michalak M. Calreticulin. Cell 1997; 88: 439-443
27. Tang D, Billiar TA, Lotze MT. A Janus tale of two active HMGB1 redox states. Mol Med 2012; 18: 1360-1362
28. Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012; 488: 670-674
29. Qin S, Wang H, Yuan R, Li H, Ochani M, Ochani K et al. Role of HMGB1 in apoptosismediated sepsis lethality. J Exp Med 2006; 203: 1637-1642
30. Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 2012; 36: 401-414
31. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med 2008; 205: 3007-3018
32. Tang D, Kang R, Zeh HJ 3rd, Lotze MT. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799: 131-140
33. Jiao Y, Wang HC, Fan SJ. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Acta Pharmacol Sin 2007; 28: 1957-1967
34. Kang R, Zhang Q, Zeh HJ, Lotze M, Tang D. HMGB1 in cancer: Good, bad, or both? Clin Cancer Res 2013; 19: 4046-4057
35. Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012; 13: 832-842
36. Vernon PJ, Loux TJ, Schapiro NE, Kang R, Muthuswamy R, Kalinski P et al. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. J Immunol 2013; 190: 1372-1379
37. Kang R, Loux T, Tang D, Schapiro NE, Vernon P, Livesey KM et al. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc Natl Acad Sci USA 2012; 109: 7031-7036
38. Kang R, Tang D, Schapiro NE, Livesey KM, Farkas A, Loughran P et al. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010; 17: 666-676
39. Luo Y, Chihara Y, Fujimoto K, Sasahira T, Kuwada M, Fujiwara R et al. High mobility group box 1 released from necrotic cells enhances regrowth and metastasis of cancer cells that have survived chemotherapy. Eur J Cancer 2013; 49: 741-751
40. Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, Billiar TR et al. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 2013; e-pub ahead of print 14 January 2013; doi:10.1038/onc.2012.631
41. Tsan MF, Gao B. Heat shock proteins and immune system. J Leukoc Biol 2009; 85: 905-910
42. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 1995; 269: 1585-1588
43. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2002; 2: 185-194
44. Corriden R, Insel PA. Basal release of ATP: An autocrine-paracrine mechanism for cell regulation. Sci Signal 2010; 3: Re1
45. Elliott MR, Chekeni FB, Trampont PC, Lazarowski ER, Kadl A, Walk SF et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009; 461: 282-286
46. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. Embo J 2012; 31: 1062-1079
47. Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007; 450: 1253-1257
48. Martinez J, Almendinger J, Oberst A, Ness R, Dillon CP, Fitzgerald P et al. Microtubule-Associated protein 1 light chain 3 alpha (LC3)-Associated phagocytosis is required for the efficient clearance of dead cells. Proc Natl Acad Sci USA 2011; 108: 17396-17401
49. Vernon PJ, Tang D. Eat-me: Autophagy, phagocytosis, and reactive oxygen species signaling. Antioxid Redox Signal 2013; 18: 677-691
50. Townsend KN, Hughson LR, Schlie K, Poon VI, Westerback A, Lum JJ. Autophagy inhibition in cancer therapy: Metabolic considerations for antitumor immunity. Immunol Rev 2012; 249: 176-194
51. Wildenberg ME, Vos AC, Wolfkamp SC, Duijvestein M, Verhaar AP, Te Velde AA et al. Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. Gastroenterology 2012; 142: 1493-1503 e1496
52. Kovacs JR, Li C, Yang Q, Li G, Garcia IG, Ju S et al. Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery. Cell Death Differ 2012; 19: 144-152
53. Li Y, Wang LX, Pang P, Twitty C, Fox BA, Aung S et al. Cross-presentation of tumor associated antigens through tumor-derived autophagosomes. Autophagy 2009; 5: 576-577
54. Li Y, Hahn T, Garrison K, Cui ZH, Thorburn A, Thorburn J et al. The vitamin E analogue alpha-TEA stimulates tumor autophagy and enhances antigen cross-presentation. Cancer Res 2012; 72: 3535-3545
55. Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 2011; 71: 5976-5986
56. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P et al. Autophagydependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334: 1573-1577
57. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P et al. Endogenous HMGB1 regulates autophagy. J Cell Biol 2010; 190: 881-892
58. Livesey KM, Kang R, Vernon P, Buchser W, Loughran P, Watkins SC et al. p53/ HMGB1 complexes regulate autophagy and apoptosis. Cancer Res 2012; 72: 1996-2005
59. Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R et al. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 2012; 72: 230-238
60. Tang D, Kang R, Livesey KM, Kroemer G, Billiar TR, Van Houten B et al. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab 2011; 13: 701-711
61. Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010; 29: 5299-5310
62. Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y et al. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia 2011; 25: 23-31
63. Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I et al. Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 2012; 7: E45427
64. Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I et al. Neutrophil extracellular trap formation is associated with IL-1beta and autophagy-related signaling in gout. PLoS One 2011; 6: E29318
65. Zhang Y, Li W, Zhu S, Jundoria A, Li J, Yang H et al. Tanshinone IIA sodium sulfonate facilitates endocytic HMGB1 uptake. Biochem Pharmacol 2012; 84: 1492-1500
66. Li W, Zhu S, Li J, Assa A, Jundoria A, Xu J et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol 2011; 81: 1152-1163
67. Zhang Q, Kang R, Zeh HJ 3rd, Lotze MT, Tang D. DAMPs and autophagy: Cellular adaptation to injury and unscheduled cell death. Autophagy 2013; 9: 451-458
68. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011; 12: 222-230
69. Henault J, Martinez J, Riggs JM, Tian J, Mehta P, Clarke L et al. Noncanonical autophagy is required for type I interferon secretion in response to dna-immune complexes. Immunity 2012; 37: 986-997
70. Biswas D, Qureshi OS, Lee WY, Croudace JE, Mura M, Lammas DA. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria within human monocytes/macrophages. BMC Immunol 2008; 9: 35
71. Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ et al. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-Talk between mitochondria and lysosomes that involves BNIP3. Cell Res 2010; 20: 314-331